What You Should Know:
- MultiCare Capital Partners, the venture arm of large health system MultiCare, today is announcing a strategic investment in Layer Health, a healthcare AI company specializing in automating chart review.
- The investment will accelerate Layer Health's growth and expand the reach of its innovative platform across the healthcare industry. Financial terms of the investment were not disclosed.
AI-Powered Chart Review
Chart review, a critical task
Read More
Atropos Health Collaborates with Merck to Accelerate Real-World Evidence Generation
What You Should Know:
- Atropos Health, a pioneer in real-world evidence (RWE) generation, announced a collaboration with Merck to leverage its innovative platform for rapid insights and analytics from real-world data (RWD).
- The strategic partnership will enable Merck's data science and RWE teams to conduct advanced analyses and generate publication-grade studies in less than 48 hours.
- The collaboration follows Atropos Health's recent launch of ChatRWD™, a groundbreaking
Read More
Innovaccer Secures $275M to Accelerate AI Innovation in Healthcare
What You Should Know:
- Innovaccer Inc., a healthcare AI company, announced today a $275M Series F funding round.
- The latest investment, combined with primary and secondary funding, includes participation from prominent investors such as B Capital Group, Banner Health, Danaher Ventures LLC, Generation Investment Management, Kaiser Permanente, and M12.
Focus on AI-Powered Solutions
Innovaccer plans to introduce multiple AI copilots and agents to its comprehensive suite of
Read More
Amwell Divests Psychiatric Care Business to Avel eCare for $21M
What You Should Know:
- Amwell (NYSE: AMWL), a leading global provider of digital care solutions, announced today the sale of its Amwell Psychiatric Care (APC) business to Avel eCare, a prominent provider of clinician-to-clinician telehealth services.
- The strategic divestiture allows Amwell to further sharpen its focus on key growth areas, drive greater efficiencies, and better align with evolving client needs in the digital health market.
Strategic Divestiture and
Read More
Eko Health Appoints Justin Spencer as Chief Financial Officer
What You Should Know:
- Eko Health, a pioneer in AI-powered heart and lung disease detection, announced today the appointment of Justin Spencer as Chief Financial Officer (CFO).
- Spencer brings a wealth of experience in scaling technology companies and driving financial success, making him a valuable addition to Eko's executive leadership team.
Spencer Bio/Background
Spencer's impressive track record includes serving as CFO at Vocera Communications, Symmetricom, and
Read More
Qure.ai Appoints Jim Mercadante as Chief Commercial Officer
What You Should Know:
- Qure.ai, a global provider of AI-powered healthcare solutions, announced the appointment of Jim Mercadante as its new Chief Commercial Officer.
- Based in New York, Mercadante will lead the company's global sales and business development strategy, driving further expansion and market penetration.
Mercadante Bio/Background
Jim Mercadante brings extensive experience in commercial leadership, sales, business growth, and strategic marketing within the
Read More
Q/A: Cedar Exec Talks The Untapped Potential of AI in Healthcare Call Centers in 2025
What if AI could dramatically reduce call volume, improve patient satisfaction, and empower your call center staff? In this exclusive interview, Dugan Winkie, Head of Commercial Strategy at Cedar, sheds light on the often-overlooked opportunity of leveraging AI in healthcare call centers.
Winkie explores the unique challenges and opportunities AI presents for providers, highlighting the potential for increased efficiency, improved patient experiences, and significant financial gains. He
Read More
FIRE1 Secures $120M for Heart Failure Management Platform
What You Should Know:
- FIRE1, a connected medical device company, announced it has secured $120M in funding to advance its mission to transform the lives of millions of people living with heart failure. The round was led by Polaris Partners and Elevage Medical Technologies, joined by new investors Sands Capital and Longitude Capital, and existing investors Andera Partners, Gilde Healthcare, Gimv, the Ireland Strategic Investment Fund, Lightstone Ventures, Medtronic, NEA (New Enterprise
Read More
Transcarent to Acquire Accolade in $621M Deal, Creating a Unified Platform for Personalized Healthcare
What You Should Know:
- Transcarent, a health and care platform, announced today that it will acquire Accolade (NASDAQ: ACCD), a leader in health advocacy and primary care, for $7.03 per share in cash, representing a total equity value of approximately $621M. The merger consideration represents a significant premium over Accolade's recent stock price, reflecting the strategic value of this transaction. Transcarent will finance the acquisition through equity financing led by
Read More
ScreenPoint Medical Acquires Biomediq to Enhance Breast Cancer Risk Assessment with AI
What You Should Know:
- ScreenPoint Medical, a provider of AI-powered breast cancer screening solutions, acquires Biomediq A/S, a research-based company specializing in quantitative imaging biomarkers. Financial details of the acquisition were not disclosed.
- ScreenPoint's industry-leading Transpara AI platform will now incorporate Biomediq's advanced risk analysis technology, which enables automated analysis of 2D and 3D mammograms to assess future breast cancer risk. This
Read More
